Journal of Clinical Medicine (Nov 2022)

Retrospective Analysis of Prognostic Factors in Pediatric Patients with Adrenocortical Tumor from Unique Tertiary Center with Long-Term Follow-Up

  • Fernanda S. Bachega,
  • Caio V. Suartz,
  • Madson Q. Almeida,
  • Vania B. Brondani,
  • Helaine L. S. Charchar,
  • Amanda M. F. Lacombe,
  • Sebastião N. Martins-Filho,
  • Iberê C. Soares,
  • Maria Claudia N. Zerbini,
  • Francisco T. Dénes,
  • Berenice Mendonca,
  • Roberto I. Lopes,
  • Ana Claudia Latronico,
  • Maria Candida B. V. Fragoso

DOI
https://doi.org/10.3390/jcm11226641
Journal volume & issue
Vol. 11, no. 22
p. 6641

Abstract

Read online

Pediatric adrenocortical tumors (PACTs) represent rare causes of malignancies. However, the south/southeast regions of Brazil are known to have a high incidence of PACTs because of the founder effect associated with a germline pathogenic variant of tumor suppressor gene TP53. We aimed to retrospectively analyze the types of variables among hormone production, radiological imaging, tumor staging, histological and genetic features that were associated with the occurrence of malignancy in 95 patients (71% females) with PACTs from a unique center. The worst prognosis was associated with those aged > 3 years (p p p p p p p p BUB1B-PINK1 (p IGF-IR overexpression (p = 0.0001) were associated with malignant behavior. These results helped identify patients who are likely to have an aggressive course; further multicenter prospective studies are required to confirm our results. In conclusion, PACTs with these patterns of prognostic factors could be treated using an adjuvant approach that may improve the overall survival in such patients.

Keywords